We believe, though, that TEP ITGA2B and SELP have great potential to be a diagnostic mRNA biomarker for NSCLC because its accuracy in the test cohort was confirmed in another independent cohort, even with a more precise method. The gene discussed is SELP; the disease is non-small cell lung carcinoma.